Patents for C12R 1 - Micro-organisms (92,025)
01/2002
01/09/2002EP1170360A1 Yunnan sl-001 strain
01/09/2002EP1170358A1 L-arginine producing Escherichia coli and method of producing L-arginine
01/09/2002EP1170016A2 Urease-based vaccine against helicobacter infection
01/09/2002EP1169468A1 Stereoselective microbial reduction for the preparation of 1-(4-fluorophenyl)-3(r)-[3(s)-hydroxy-3-(4-fluorophenyl)propyl)]-4(s)-(4-hydroxyphenyl)-2-azetidinone
01/09/2002EP1169467A1 Process for the preparation of prostaglandin precursors
01/09/2002EP1169466A1 Synthesis of 1,2,3,4-tetrahydroxybenzenes and 1,2,3-trihydroxybenzenes using myo-inositol-1-phosphate synthase and myo-inositol 2-dehydrogenase
01/09/2002EP1169465A1 Two-step immunization procedure against chlamydia infection
01/09/2002EP1169461A2 Production of pancreatic procarboxy-peptidase b, isoforms and muteins thereof, and their use
01/09/2002EP1169457A2 Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences
01/09/2002EP1169456A1 Recombinant toxin a/toxin b vaccine against clostridium difficile
01/09/2002EP1169455A1 Compounds and methods for the diagnosis and treatment of babesia microti infection
01/09/2002EP1169442A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
01/09/2002EP1169432A1 Process for the production of yeast biomass comprising functionally deleted hxk2 genes
01/09/2002EP1169350A2 Human obesity protein binding protein-2 homolog compositions and uses thereof
01/09/2002EP1169346A1 48 human secreted proteins
01/09/2002EP1169342A2 Tuberculosis antigens and methods of use therefor
01/09/2002EP1169340A1 Lantibiotic
01/09/2002EP1169333A1 49 human secreted proteins
01/09/2002EP1169063A2 Treatment of intracellular infection
01/09/2002EP1168922A1 Biological compositions and methods for enhancing plant growth and health and producing disease-suppressive plants
01/09/2002EP1009812A4 Transgenic plants with tocopherol methyltransferase
01/09/2002EP0789764B1 A novel family of protease inhibitors, and other biologic active substances
01/09/2002EP0767610B1 Bacillus thuringiensis isolates active against cockroaches
01/09/2002EP0714444B1 Dampening of an immunodominant epitope of an antigen for use in plant, animal and human vaccines and immunotherapies
01/09/2002EP0553280B1 Methods for treating cotton-containing fabrics with cellulase
01/09/2002EP0495811B1 Production of genetically-engineered vaccines for aids and other retroviral diseases
01/09/2002CN1330721A Resolution of trans-2-(alkoxycarbonylethyl)-laitams useful in synthesis of 1-(4-fluorophenyl)-3(R)-[3(s)-hydroxy-3-(flurophenyl)-propyl)]-4(s)-(4-hydroxyphenyl)-2-azetidinone
01/09/2002CN1330718A Therapeutically active proteins in plants
01/09/2002CN1330662A Heliobacter pylori antigen
01/09/2002CN1077599C Enzymatic hydrolysis of 4-methylthiobutyronitriles
01/09/2002CN1077598C Method for preparing variant of lipolytic enzyme
01/09/2002CN1077563C Process for preparation of citraconic anhydride
01/09/2002CN1077438C Recombinant coccidiosis vaccines
01/08/2002US6337411 Muscular disorders
01/08/2002US6337209 Molecular constructs containing a carcinoembryonic antigen regulatory sequence
01/08/2002US6337196 Enzymatic processes for preparing (S)-cyanohydrins
01/08/2002CA2083695C Hv/hb copolymer production
01/08/2002CA2021594C Antibody to human interleukin-6 receptor
01/08/2002CA2019559C Bispecific and oligospecific mono- and oligovalent receptors, the preparation and use thereof
01/08/2002CA1341332C Method for obtaining protective antigens against bordetella infections and toxic processes
01/03/2002WO2002000912A1 Process for treating with enzyme
01/03/2002WO2002000907A1 Method for stable chromosomal multi-copy integration of genes
01/03/2002WO2002000858A2 Methods and compositions for simultaneous saccharification and fermentation
01/03/2002WO2002000845A1 Enhanced flavour production in or relating to food by cultivation of various food-grade micro-organisms
01/03/2002WO2002000663A2 Polycyclic xanthones as antibiotics
01/03/2002WO2002000600A1 Use of compositions consisting of cationic compounds and proton donors for stabilising and/or isolating nucleic acids in or from micro-organisms such as prokaryots, fungi, protozoa or algae
01/03/2002WO2002000599A1 Novel compositions for isolating and/or stabilising nucleic acids in biological material
01/03/2002WO2001066767A3 Direct production of desacetylcephalosporin c
01/03/2002US20020002715 Gene expression cassettes
01/03/2002US20020002275 Novel nucleotide sequences encoding the gpm gene
01/03/2002US20020002273 Rapamycin assay
01/03/2002US20020001833 Solventless extraction process
01/03/2002US20020001824 Ligand-gated anion channels of insects
01/03/2002US20020001798 Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
01/03/2002US20020001641 Persimmon vinegar and preparation therefor
01/03/2002CA2413431A1 Enhanced flavour production in or relating to food by cultivation of various food-grade micro-organisms
01/03/2002CA2412559A1 Polycyclic xanthones as antibiotics
01/03/2002CA2411479A1 Methods and compositions for simultaneous saccharification and fermentation
01/03/2002CA2410388A1 Use of compositions consisting of cationic compounds and proton donors for stabilising and/or isolating nucleic acids in or from micro-organisms such as prokaryotes, fungi, protozoa or algae
01/02/2002EP1167544A2 Probe for diagnosing infectious disease arising from Escherichia coli, Klebsiella pneumoniae or Enterobacter cloacae
01/02/2002EP1167543A2 Probe for diagnosing infectious disease arising from Staphylococcus epidermidis
01/02/2002EP1167542A2 Probe for diagnosing infectious disease arising from Enterococcus faecalis
01/02/2002EP1167534A2 Process for the preparation of optically active 1,2-diols by cultivating microorganisms
01/02/2002EP1167516A2 Aromatic compound-degrading bacteria and use thereof
01/02/2002EP1167385A2 Human follicle stimulating hormone receptor
01/02/2002EP1167374A1 Glycosphingolipid
01/02/2002EP1165810A2 Transducing phages
01/02/2002EP1165807A1 A protease, a gene therefor and the use thereof
01/02/2002EP1165803A2 Enzymes of the biosynthetic pathway for the production of triacylglycerol and recombinant dna molecules encoding these enzymes
01/02/2002EP1165795A2 Streptococcus pneumoniae antigens
01/02/2002EP1165763A1 Hydantoinase variants with improved properties and their use for the production of amino acids
01/02/2002EP1165762A2 Alpha-amylase variants
01/02/2002EP1165759A1 Polypeptides having branching enzyme activity and nucleic acids encoding same
01/02/2002EP1165758A2 Regulation of the expression of transcriptional repressor genes using nucleic acid molecules
01/02/2002EP1165756A2 Adaptation of virus to vertebrate cells
01/02/2002EP1165755A1 Banana and melon promoters for expression of transgenes in plants
01/02/2002EP1165751A1 A strain of bacillus pumilus for controlling plant diseases
01/02/2002EP1165750A1 Diagnosis of whipple disease
01/02/2002EP1165748A1 Method and apparatus for ultrasonic lysis of biological cells
01/02/2002EP1165615A2 MONOCLONAL ANTIBODIES AGAINST HUMAN PROTEIN Mcm3, PROCESS FOR THEIR PRODUCTION, AND THEIR USE
01/02/2002EP1165124A1 Recombinant neospora antigens and their uses
01/02/2002EP1165104A1 Lactic acid bacteria strains capable of preventing diarrhoea
01/02/2002EP1165100A2 Methods of treating schizophrenia
01/02/2002EP1105380A4 Process for the preparation of c-4 deacetyltaxanes
01/02/2002EP0783039B1 Process for producing optically active 2-alkoxycyclohexanol derivatives
01/02/2002CN1329670A Plants and plants cells encoding wild type COP1 gene and coil domain thereof
01/02/2002CN1329667A Fungal transcriptional activator useful in methods for producing polyptides
01/02/2002CN1329665A Gluocoamylases with N-terminal extensions
01/02/2002CN1077139C Process for producing L-amino acids
01/01/2002US6335433 nrdD
01/01/2002US6335182 Recombinant Haemophilus influenzae adhesin proteins
01/01/2002US6335181 Generating polypeptide; for use in the diagnosis, prevention and treatment of bacterial infection
01/01/2002US6335158 Immunologically active peptide of given amino acid sequence which binds antibodies against retroviruses of the hiv type; diagnostic kits
01/01/2002US6335016 Chicken embryo lethal orphan (CELO) virus
01/01/2002CA1341331C Viral vector and recombinant dna coding for one or more structural protein (ha, f and/or np) of a morbillivirus, infected cell culture, resulting proteins, vaccine and antibodies
12/2001
12/28/2001CA2351913A1 Process for preparation of optically active 1,2-diols by cultivating microorganisms
12/27/2001WO2001098477A1 Immobilising carrier comprising a porous medium
12/27/2001WO2001098470A2 Recombinant proteolytic tryptases, active site mutants thereof, and methods of making same
12/27/2001WO2001098435A2 Avalon biopreparation for removing petrol and petrol products from environmental sites and method for producing said biopreparation
12/27/2001WO2001098356A1 Low oxygen affinity mutant hemoglobins